Testing an e-Health Intervention for Prostate Cancer Survivors' Mental and Sexual Health
Launched by UNIVERSIDADE DO PORTO · Jul 13, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new online program designed to help men who have survived prostate cancer improve their mental health, sexual health, and overall quality of life. The study will involve prostate cancer survivors who will be divided into two groups: one group will use the e-Health program, while the other group will be on a waiting list and not receive the program right away. Researchers want to see if the men using the program feel better in terms of their mental and sexual well-being compared to those who are waiting.
To join the study, participants need to be at least 18 years old, have survived prostate cancer, and be comfortable using a smartphone and the internet. However, those with other serious health issues, certain psychological conditions, or who are currently undergoing other treatments cannot participate. This trial is important because it will help researchers understand how effective the e-Health program is and may lead to a larger study in the future to further investigate its benefits for prostate cancer survivors.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Prostate cancer survivors,
- • 18 years old or older,
- • Ability to give informed consent,
- • Regular use of a smartphone and internet access.
- Exclusion Criteria:
- • Other diagnosed oncological diseases over the past five years,
- • Severe neurological impairment or other severe psychological/psychiatric diseases (depression, generalized anxiety disorder, psychosis-related disorders),
- • Other uncontrolled/unstable diseases,
- • Severe hearing and/or visual impairment,
- • Under psychotherapy or treatment for sexual problems,
- • Participating concurrently in other clinical trials.
About Universidade Do Porto
The Universidade do Porto, one of Portugal's leading academic institutions, is dedicated to advancing medical research and innovation through its clinical trial sponsorship. With a robust framework for interdisciplinary collaboration, the university fosters an environment that encourages the exploration of cutting-edge therapies and healthcare solutions. Leveraging its extensive network of researchers, clinical practitioners, and state-of-the-art facilities, the Universidade do Porto is committed to conducting high-quality, ethical clinical trials aimed at improving patient outcomes and contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto, , Portugal
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported